FSMAX
Price
$101.54
Change
-$1.22 (-1.19%)
Updated
Oct 7 closing price
Net Assets
41.44B
LGOQX
Price
$27.58
Change
-$0.09 (-0.33%)
Updated
Oct 7 closing price
Net Assets
717.5M
Interact to see
Advertisement

FSMAX vs LGOQX

Header iconFSMAX vs LGOQX Comparison
Open Charts FSMAX vs LGOQXBanner chart's image
Fidelity Extended Market Index
Price$101.54
Change-$1.22 (-1.19%)
VolumeN/A
Net Assets41.44B
Lord Abbett Growth Opportunities R2
Price$27.58
Change-$0.09 (-0.33%)
VolumeN/A
Net Assets717.5M
FSMAX vs LGOQX Comparison Chart in %
View a ticker or compare two or three
VS
FSMAX vs. LGOQX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Hold and LGOQX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 41.4B vs. LGOQX (717M). FSMAX pays higher dividends than LGOQX: FSMAX (0.44) vs LGOQX (0.00). FSMAX was incepted earlier than LGOQX: FSMAX (14 years) vs LGOQX (18 years). LGOQX (1.50) is less costly to investors than FSMAX (0.04). LGOQX is a more actively managed with annual turnover of: 117.00 vs. FSMAX (9.00). FSMAX (0) and LGOQX (0) have matching initial minimum investment requirements. LGOQX annual gain was more profitable for investors over the last year : 32.84 vs. FSMAX (19.58). FSMAX return over 5 years is better than : 53.17 vs. LGOQX (-0.29).
FSMAXLGOQXFSMAX / LGOQX
Total Expense Ratio0.041.313%
Annual Report Gross Expense Ratio0.041.502%
Fund Existence14 years18 years-
Gain YTD13.07221.30661%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets41.4B717M5,774%
Annual Yield % from dividends0.440.00-
Returns for 1 year19.5832.8460%
Returns for 3 years70.0272.4097%
Returns for 5 years53.17-0.29-18,443%
Returns for 10 years107.2335.17305%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AARD17.410.36
+2.11%
Aardvark Therapeutics Inc
CASH74.520.52
+0.70%
Pathward Financial
RAAQU10.330.03
+0.29%
Real Asset Acquisition Corp.
FRT97.60-1.14
-1.15%
Federal Realty Investment Trust
SKYE1.66-0.24
-12.63%
Skye Bioscience